Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
02/1996
02/07/1996EP0695423A1 Polymer containing control reagents and polymers useful in control reagents
02/07/1996EP0695421A1 Method of measuring chemiluminescence of multiple samples on a continuous matrix
02/07/1996EP0695420A1 Monitoring soil compaction
02/07/1996EP0695419A1 Method and apparatus for compacting material samples
02/07/1996EP0695365A1 Extender containing polymer compositions and uses thereof
02/07/1996EP0695312A1 Immunoparticles bearing monoclonal anti-cd4 antibodies and utilisation thereof
02/07/1996EP0695311A1 Cellulose binding domain
02/07/1996EP0695310A1 A method of detecting the presence of and converting of a polypeptide
02/07/1996EP0642664A4 Assays for o?6 -methylguanine-dna methyltransferase.
02/07/1996EP0634014A4 Hair analysis method.
02/07/1996EP0581915B1 Electrode for determining the state of corrosion of metal reinforcement in concrete constructions
02/07/1996EP0553229B1 Improvement in solid phase binding assay
02/07/1996EP0517835B1 Automated biological reaction apparatus
02/07/1996EP0420848B1 Carcinoma-associated antigens, and antibodies which recognize these antigens
02/07/1996EP0305491B1 System for isolating and identifying leukocytes
02/07/1996CN1116307A Minimum procedure system for the decermination of analytes
02/07/1996CN1116306A Automatic testing method and apparatus for erythrocyte rheological parameter
02/06/1996US5490085 Method for optimizing control of a production unit
02/06/1996US5489977 Photomeric means for monitoring solids and fluorescent material in waste water using a falling stream water sampler
02/06/1996US5489778 Process and installation for the identification of materials
02/06/1996US5489777 Apparatus for remote analysis of vehicle emissions using reflective thermography
02/06/1996US5489668 Immunoassay reagents and method for determining cyclosporine
02/06/1996US5489653 Water-soluble compounds derived from homopolymer or copolymer of maleic anhydride, and applications of the said compounds to supporting biological molecules
02/06/1996US5489537 Agglutination assays and kits employing colloidal dyes
02/06/1996US5489536 Using fluorescent indicator in polymer matrix; light source and spectrophotometer
02/06/1996US5489533 Human intercellular adhesion molecule-2; antiinflammatory agents
02/06/1996US5489530 Active at ph 3.5-9.0 and not inhibited by sodium deoxycholate; used for producing drugs for therapy of maldigestion
02/06/1996US5489528 Recombinant core-streptavidin
02/06/1996US5489524 Chimeric protein that has a human Rho motif and deoxyribonuclease activity
02/06/1996US5489519 Multidrug resistance protein
02/06/1996US5489516 Hybridoma and monoclonal antibody specific for human stem cell factor receptor and methods of use of the monoclonal antibody for detection of stem cell factor receptors
02/06/1996US5489515 For measuring ph variations in culture liquids
02/06/1996US5489510 Complexing of cholesterol with enzymatic agent and indicator
02/06/1996US5489508 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
02/06/1996US5489414 System for analyzing compounds contained in liquid samples
02/06/1996US5489386 Density gradient medium for the separation of cells
02/06/1996US5489371 Porous electrode positioned on semipermeable membrane for detecting and measuring concentration of compounds extracted from high resistivity liquid
02/06/1996US5488856 Monitor for growth and deposit
02/06/1996US5488855 Test kit used for retrofillig a mechanical vapor recompression type heat transfer system with a hydrohalocarbon working fluid; visual observation for turbidity or clarity
02/06/1996US5488816 Method and apparatus for manufacturing a coagulation assay device in a continuous manner
02/06/1996CA2129594A1 Sampler and desorber unit for detection of drug and explosive particulates
02/06/1996CA2077185C Direct sampling of engine emissions for instantaneous analysis
02/06/1996CA2019015C Optical read system and immunoassay method
02/06/1996CA1338032C Apolipoprotein b-specific monoclonal antibodies produced by two novel hybridomas
02/05/1996CA2155397A1 Novel mutant br96 antibodies and functional equivalents reactive with human carcinomas
02/04/1996CA2151667A1 Method for classifying and counting leukocytes
02/02/1996WO1996004399A1 Quick biochemical oxygen demand test and apparatus for the same
02/01/1996WO1996002891A1 Method for determining alcohol consumption rates
02/01/1996WO1996002842A1 Methods and compositions for the determination of red blood cell folate
02/01/1996WO1996002841A1 Methods and reagents for cyanide-free determination of hemoglobin and leukocytes in whole blood
02/01/1996WO1996002840A1 Method for determining the lysine content of seeds
02/01/1996WO1996002839A1 Chemiluminescent signal enhancement
02/01/1996WO1996002838A1 Glutathione modified surfaces
02/01/1996WO1996002837A1 Apparatus and method for the detection and assay of organic molecules
02/01/1996WO1996002836A1 Automatic processing system for use in solid phase biospecific binding and dna sequencing techniques
02/01/1996WO1996002835A1 Method and apparatus for non-destructive elemental analysis of the headspace of a sealed container
02/01/1996WO1996002830A1 Biosensor and method and instrument for deposition of alternating monomolecular layers
02/01/1996WO1996002828A1 Methods and apparatus for rapid equilibration of dissolved gas composition
02/01/1996WO1996002821A1 Method and apparatus for on-line measurement of pulp fibre surface development
02/01/1996WO1996002818A1 Device for continuously sampling and analysing a liquid effluent
02/01/1996WO1996002674A1 Genetic diagnosis of prostate cancer
02/01/1996WO1996002667A1 Assays and devices for the detection of extrahepatic biliary atresia
02/01/1996WO1996002666A1 Capture assays
02/01/1996WO1996002665A1 Microbiological test method and reagents
02/01/1996WO1996002645A2 Htk ligand
02/01/1996WO1996002643A1 Denervated muscle kinase (dmk), a receptor of the tyrosine kinase super family
02/01/1996WO1996002642A1 INTERRUPTION OF BINDING OF MDM2 AND p53 PROTEIN AND THERAPEUTIC APPLICATION THEREOF
02/01/1996WO1996002613A1 Use of benzaldehydes to mark hydrocarbons
02/01/1996WO1996002575A1 Articles of manufacture for removing hiv-1 from a sample, and methods of using same
02/01/1996WO1996002574A1 Process for modifying the stability of antibodies
02/01/1996WO1996002572A2 Antigenic polypeptide sequence of factor viii, fragments and/or epitopes thereof
02/01/1996WO1996002566A1 Vitronectin binding protein
02/01/1996WO1996002561A1 Interaction trap systems for detecting protein interactions
02/01/1996WO1996002559A1 Growth differentiation factor-12
02/01/1996WO1996002552A1 Lung cancer marker
02/01/1996WO1996002273A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus
02/01/1996WO1996002265A1 The cellular basis of transplant arteriosclerosis
02/01/1996WO1996002251A1 Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists
02/01/1996WO1996002235A1 Injectable res avoiding inorganic particles
02/01/1996WO1996002191A1 Method and apparatus for oriented biopsy storage
02/01/1996DE4440577C1 Appts. for taking samples of molten metal
02/01/1996DE4439347A1 New rare earth or transition metal complexes contg. charged linker
02/01/1996DE4439346A1 New rare earth or transition metal complexes contg. hydrophilic gps.
02/01/1996DE4439345A1 New conjugates comprising oligomeric carrier and attached hapten(s)
02/01/1996DE4430998A1 Metallchelat-markierte Peptide Metal chelate-labeled peptides
02/01/1996DE4430973A1 Hapten-markierte Peptide Hapten-labeled peptides
02/01/1996DE4430972A1 Bestimmung von spezifischem Immunglobulin unter Verwendung multipler Antigene Determination of specific immunoglobulin using multiple antigens
02/01/1996DE4429409C1 Immunological detection of tumour markers, esp. thyroglobulin
02/01/1996DE4427821A1 Stabilised super-paramagnetic aggregate particles
02/01/1996DE4426524A1 Presentation of fibre flows for detection
02/01/1996DE4426056A1 Determn. of protein content of biological samples
02/01/1996CA2195533A1 Interruption of binding of mdm2 and p53 protein and therapeutic application thereof
02/01/1996CA2195454A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus
02/01/1996CA2195403A1 Lung cancer marker
02/01/1996CA2195246A1 Growth differentiation factor-12
02/01/1996CA2195205A1 Method for determining the lysine content of seeds
02/01/1996CA2195197A1 Corticotropin-releasing factor-binding-protein inhibitors and their use
02/01/1996CA2195126A1 Antigenic polypeptide sequence of factor viii, fragments and/or epitopes thereof
02/01/1996CA2195122A1 Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists
02/01/1996CA2195019A1 Use of benzaldehydes to mark hydrocarbons